Victoza

Released: January 15, 2026Last reviewed: October 15, 2026

Brand name for liraglutide 1.8 mg daily, FDA-approved for type 2 diabetes mellitus.

By Novo NordiskUpdated 2026-05-25

Researched By

Dr. Parmis

Medical Researcher · Western University of Health Sciences

Medically Reviewed By

Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: October 15, 2026 · This page is informational and does not constitute medical advice.

Victoza overview

Brand name for liraglutide 1.8 mg daily, FDA-approved for type 2 diabetes mellitus.

Manufacturer

Novo Nordisk

FDA status

FDA-approved

Victoza